Page last updated: 2024-08-21

caprolactone and Prostatic Neoplasms

caprolactone has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farach-Carson, MC; Gurski, LA; Jia, X; Pochan, DJ; Wang, X; Xu, X; Zhong, S1

Other Studies

1 other study(ies) available for caprolactone and Prostatic Neoplasms

ArticleYear
Amphiphilic block co-polyesters bearing pendant cyclic ketal groups as nanocarriers for controlled release of camptothecin.
    Journal of biomaterials science. Polymer edition, 2011, Volume: 22, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Camptothecin; Caproates; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Drug Carriers; Glass; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Lactones; Male; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Prostatic Neoplasms; Surface-Active Agents; Transition Temperature

2011